Transitional Cell Carcinoma

Transitional cell carcinoma, also called urothelial carcinoma, is a type of cancer that typically occurs in the urinary system, which includes the kidneys, the bladder and the tubes that connects them. It is the most common type of bladder cancer (about 95% of bladder cancer cases). It is rarer to occur in the kidney.

Showing 13–18 of 18 results

Filter our product list:
API
Antigen / Target
Therapeutic Areas
Therapeutic Indications
1
Classes of molecule​s
Isotypes
Expiry Date
CoA
Filters Sort results
Reset Apply

Product
Batch

Antigen
Molecular Class
Drug Brand
Product Concentration
CoA
Quantity per vial
Storage Temperature
Expiry Date
Price from
PD-1
Monoclonal Antibody
Opdivo®
10 mg/mL
2 mg
-80°C
08/2024
307,00 
view product
Max: 10
Min: 1
Step: 1
PD-1
Monoclonal Antibody
Opdivo®
10 mg/mL
2 mg
-80°C
08/2025
307,00 
view product
Max: 10
Min: 1
Step: 1
PD-1
Monoclonal Antibody
Opdivo®
10 mg/mL
2 mg
-80°C
03/2025
307,00 
view product
Max: 10
Min: 1
Step: 1
PD-1
Monoclonal Antibody
Opdivo®
10 mg/mL
2 mg
-80°C
08/2018
276,30 
view product
Max: 10
Min: 1
Step: 1
PD-1
Monoclonal Antibody
Opdivo®
10 mg/mL
2 mg
-80°C
10/2018
276,30 
view product
Max: 10
Min: 1
Step: 1
PD-1
Monoclonal Antibody
Opdivo®
10 mg/mL
2 mg
-80°C
02/2018
276,30 
view product
Max: 10
Min: 1
Step: 1
PD-1
Monoclonal Antibody
Opdivo®
10 mg/mL
2 mg
-80°C
05/2019
276,30 
view product
Max: 7
Min: 1
Step: 1
PD-1
Monoclonal Antibody
Opdivo®
10 mg/mL
2 mg
-80°C
01/2019
276,30 
view product
Max: 10
Min: 1
Step: 1
PD-1
Monoclonal Antibody
Opdivo®
10 mg/mL
2 mg
-80°C
09/2020
276,30 
view product
Max: 7
Min: 1
Step: 1
PD-1
Monoclonal Antibody
Opdivo®
10 mg/mL
2 mg
-80°C
11/2020
276,30 
view product
Max: 10
Min: 1
Step: 1
PD-1
Monoclonal Antibody
Opdivo®
10 mg/mL
2 mg
-80°C
02/2021
276,30 
view product
Max: 6
Min: 1
Step: 1
PD-1
Monoclonal Antibody
Keytruda®
25 mg/mL
2 mg
-80°C
07/2018
451,80 
view product
Max: 10
Min: 1
Step: 1
PD-1
Monoclonal Antibody
Keytruda®
25 mg/mL
2 mg
-80°C
12/2018
451,80 
view product
Max: 10
Min: 1
Step: 1
PD-1
Monoclonal Antibody
Keytruda®
25 mg/mL
2 mg
-80°C
03/2019
451,80 
view product
Max: 10
Min: 1
Step: 1
PD-1
Monoclonal Antibody
Keytruda®
25 mg/mL
2 mg
-80°C
07/2019
451,80 
view product
Max: 10
Min: 1
Step: 1
PD-1
Monoclonal Antibody
Keytruda®
25 mg/mL
yes
2 mg
-80°C
04/2022
564,30 
view product
Max: 10
Min: 1
Step: 1
PD-1
Monoclonal Antibody
Keytruda®
25 mg/mL
2 mg
-80°C
11/2022
451,80 
view product
Max: 2
Min: 1
Step: 1
PD-1
Monoclonal Antibody
Keytruda®
25 mg/mL
2 mg
-80°C
04/2024
502,00 
view product
Max: 10
Min: 1
Step: 1

Not looking for Transitional Cell Carcinoma?

Search our therapeutic molecules product database